1. Anderson RM, May RM: Immunisation and herd immunity.
Lancet 1990, 335:641-645.
2. Nathanson N, Moss WJ: Epidemiology. In Fields Virology. Edited
b31y 4K-3n3ip7e. DM, Howley PM. Lippincott, Williams & Wilkins; 2013:
3. Moonen P, Schrijver R: Carriers of foot-and-mouth disease
virus: a review. Vet Q 2000, 22:193-197.
4. Salt JS: The carrier state in foot and mouth disease—an
immunological review. Br Vet J 1993, 149:207-223.
5. Kristensson K, Norrby E: Persistence of RNA viruses in the
central nervous system. Annu Rev Microbiol 1986, 40:159-184.
6. Garg RK: Subacute sclerosing panencephalitis. Postgrad Med J
2002, 78:63-70.
7. Griffin DE, Lin WH, Pan CH: Measles virus, immune control, and
persistence. FEMS Microbiol Rev 2012, 36:649-662.
8. Lin F, Mackay DK, Knowles NJ: The persistence of swine
vesicular disease virus infection in pigs. Epidemiol Infect 1998,
121:459-472.
9. Zlateva KT, de Vries JJ, Coenjaerts FE, van Loon AM, Verheij T,
Little P, Butler CC, Goossens H, Ieven M, Claas EC et al.:
Prolonged shedding of rhinovirus and re-infection in adults
with respiratory tract illness. Eur Respir J 2014, 44:169-177.
10. Loeffelholz MJ, Trujillo R, Pyles RB, Miller AL, Alvarez-
Fernandez P, Pong DL, Chonmaitree T: Duration of rhinovirus
shedding in the upper respiratory tract in the first year of life.
Pediatrics 2014, 134:1144-1150.
RNA virus persistence Randall and Griffin 39
www.sciencedirect.com Current Opinion in Virology 2017, 23:35–42
11. Randall RE, Russell WC: Paramyxovirus persistence.
Consequences for host and virus. In The Paramyxoviruses.
Edited by Kingsbury DW. Plenum Press; 1991:299-321.
12. Nuttall PA, Jones LD, Labuda M, Kaufman WR: Adaptations of
arboviruses to ticks. J Med Entomol 1994, 31:1-9.
13. Kuno G: Persistence of arboviruses and antiviral antibodies in
vertebrate hosts: its occurrence and impacts. Rev Med Virol
2001, 11:165-190.
14. Heeney JL: Ebola hidden reservoirs. Nature 2015, 527:453-455.
15. Harrower J, Kiedrzynski T, Baker S, Upton A, Rahnama F,
Sherwood J, Huang QS, Todd A, Pulford D: Sexual transmission
of Zika virus and persistence in Semen, New Zealand, 2016.
Emerg Infect Dis 2016, 22:1855-1857.
16. Lin WH, Kouyos RD, Adams RJ, Grenfell BT, Griffin DE: Prolonged
persistence of measles virus RNA is characteristic of
primary infection dynamics. Proc Natl Acad Sci U S A 2012,
109:14989-14994.
17. Panum PL: lagttageiser anstillede under maeslingeapidemieu
paa faeroernei aaret 1846. Bibliothek Laeger 1847, 1:270-344.
18. McGivern DR, Lemon SM: Virus-specific mechanisms of
carcinogenesis in hepatitis C virus associated liver cancer.
Oncogene 2011, 30:1969-1983.
19. Miller KD, Schnell MJ, Rall GF: Keeping it in check: chronic viral
infection and antiviral immunity in the brain. Nat Rev Neurosci
2016, 17:766-776.
20. Jacobs M, Rodger A, Bell DJ, Bhagani S, Cropley I, Filipe A,
Gifford RJ, Hopkins S, Hughes J, Jabeen F et al.: Late Ebola virus
relapse causing meningoencephalitis: a case report. Lancet
2016, 388:498-503.
21. MacLachlan NJ, Nunamaker RA, Katz JB, Sawyer MM, Akita GY,
Osburn BI, Tabachnick WJ: Detection of bluetongue virus in the
blood of inoculated calves: comparison of virus isolation, PCR
assay, and in vitro feeding of Culicoides variipennis. Arch Virol
1994, 136:1-8.
22. Schwartz-Cornil I, Mertens PP, Contreras V, Hemati B, Pascale F,
Breard E, Mellor PS, MacLachlan NJ, Zientara S: Bluetongue
virus: virology, pathogenesis and immunity. Vet Res 2008,
39:46.
23. Whetter LE, Maclachlan NJ, Gebhard DH, Heidner HW, Moore PF:
Bluetongue virus infection of bovine monocytes. J Gen Virol
1989, 70(Pt. 7):1663-1676.
24. Li Y, Masaki T, Yamane D, McGivern DR, Lemon SM: Competing
and noncompeting activities of miR-122 and the 5’
exonuclease Xrn1 in regulation of hepatitis C virus replication.
Proc Natl Acad Sci U S A 2013, 110:1881-1886.
25. Sarnow P, Sagan SM: Unraveling the mysterious interactions
between hepatitis C virus RNA and liver-specific microRNA-
122. Annu Rev Virol 2016, 3:309-332.
26. Tomonaga K, Kobayashi T, Ikuta K: Molecular and cellular
biology of Borna disease virus infection. Microbes Infect 2002,
4:491-500.
27. Matsumoto Y, Hayashi Y, Omori H, Honda T, Daito T, Horie M,
Ikuta K, Fujino K, Nakamura S, Schneider U et al.: Bornavirus
closely associates and segregates with host chromosomes to
ensure persistent intranuclear infection. Cell Host Microbe
2012, 11:492-503.
28. Poenisch M, Burger N, Staeheli P, Bauer G, Schneider U: Protein
X of Borna disease virus inhibits apoptosis and promotes viral
persistence in the central nervous systems of newborninfected
rats. J Virol 2009, 83:4297-4307.
29. Schneider U: Novel insights into the regulation of the viral
polymerase complex of neurotropic Borna disease virus. Virus
Res 2005, 111:148-160.
30. Schneider U, Martin A, Schwemmle M, Staeheli P: Genome
trimming by Borna disease viruses: viral replication control or
escape from cellular surveillance. Cell Mol Life Sci 2007,
64:1038-1042.
31. Kim KS, Tracy S, Tapprich W, Bailey J, Lee CK, Kim K, Barry WH:
Chapman NM: 5’-terminal deletions occur in coxsackievirus
B3 during replication in murine hearts and cardiac myocyte
cultures and correlate with encapsidation of negative-strand
viral RNA. J Virol 2005, 79:7024-7041.
32. Meyer BJ, Southern PJ: A novel type of defective viral genome
suggests a unique strategy to establish and maintain
persistent lymphocytic choriomeningitis virus infections.
J Virol 1997, 71:6757-6764.
33. Meyer BJ, Schmaljohn CS: Persistent hantavirus infections:
characteristics and mechanisms. Trends Microbiol 2000,
8:61-67.
34. Lan H, Wang H, Chen Q, Chen H, Jia D, Mao Q, Wei T: Small
interfering RNA pathway modulates persistent infection of a
plant virus in its insect vector. Sci Rep 2016, 6:20699.
35. Goic B, Vodovar N, Mondotte JA, Monot C, Frangeul L, Blanc H,
Gausson V, Vera-Otarola J, Cristofari G, Saleh MC: RNA-
mediated interference and reverse transcription control the
persistence of RNA viruses in the insect model Drosophila.
Nat Immunol 2013, 14:396-403.
36. Myles KM, Wiley MR, Morazzani EM, Adelman ZN: Alphavirus-
derived small RNAs modulate pathogenesis in disease vector
mosquitoes. Proc Natl Acad Sci U S A 2008, 105:19938-19943.
37. Klein SL, Calisher CH: Emergence and persistence of
hantaviruses. Curr Top Microbiol Immunol 2007, 315:217-252.
38. Ermonval M, Baychelier F, Tordo N: What do we know about how
Hantaviruses interact with their different hosts?
Viruses 2016, 8.
39. Younger JS: Temperature-sensitive viruses: possible role in
chronic and inapparent infections. In Slow Virus Infectins of the
Central Nervous Systems. Edited by ter Meulen V, Katz M.
Springer-Veriag; 1977:222-227.
40. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R:
Quasispecies diversity determines pathogenesis through
cooperative interactions in a viral population. Nature 2006,
439:344-348.
41. Sanz-Ramos M, Diaz-San Segundo F, Escarmis C, Domingo E,
Sevilla N: Hidden virulence determinants in a viral quasispecies
in vivo. J Virol 2008, 82:10465-10476.
42. Domingo E, Baranowski E, Ruiz-Jarabo CM, Martin-
Hernandez AM, Saiz JC, Escarmis C: Quasispecies structure
and persistence of RNA viruses. Emerg Infect Dis 1998,
4:521-527.
43. Domingo E, Sheldon J, Perales C: Viral quasispecies evolution.
Microbiol Mol Biol Rev 2012, 76:159-216.
44. Holland JJ, Kennedy IT, Semler BL, Jones CL, Roux L, Grabau EA:
Defective interfering RNA viruses and the host-cell response.
In Comprehensive Virology, vol. 16. Edited by Fraenkel-Conrat H,
Wagner RR. Plenum Press; 1980:137-192.
45. Roux L, Simon AE, Holland JJ: Effects of defective interfering
viruses on virus replication and pathogenesis in vitro and in
vivo. Adv Virus Res 1991, 40:181-211.
46. Sidhu MS, Crowley J, Lowenthal A, Karcher D, Menonna J,
Cook S, Udem S, Dowling P: Defective measles virus in human
subacute sclerosing panencephalitis brain. Virology 1994,
202:631-641.
47. Zhdanov VM: Integration of viral genomes. Nature 1975,
256:471-473.
48. Geuking MB, Weber J, Dewannieux M, Gorelik E, Heidmann T,
Hengartner H, Zinkernagel RM, Hangartner L: Recombination of
retrotransposon and exogenous RNA virus results in
nonretroviral cDNA integration. Science 2009, 323:393-396.
49. Klenerman P, Hengartner H, Zinkernagel RM: A non-retroviral
RNA virus persists in DNA form. Nature 1997, 390:298-301.
50. Horie M, Honda T, Suzuki Y, Kobayashi Y, Daito T, Oshida T,
Ikuta K, Jern P, Gojobori T, Coffin JM et al.: Endogenous
non-retroviral RNA virus elements in mammalian genomes.
Nature 2010, 463:84-87.
40 Viral pathogenesis
Current Opinion in Virology 2017, 23:35–42 www.sciencedirect.com
51. Lanford RE, Feng Z, Chavez D, Guerra B, Brasky KM, Zhou Y,
Yamane D, Perelson AS, Walker CM, Lemon SM: Acute hepatitis
A virus infection is associated with a limited type I interferon
response and persistence of intrahepatic viral RNA. Proc Natl
Acad Sci U S A 2011, 108:11223-11228.
52. Schultz KL, Vernon PS, Griffin DE: Differentiation of neurons
restricts Arbovirus replication and increases expression of the
alpha isoform of IRF-7. J Virol 2015, 89:48-60.
53. Chatziandreou N, Young D, Andrejeva J, Goodbourn S,
Randall RE: Differences in interferon sensitivity and biological
properties of two related isolates of simian virus 5: a model for
virus persistence. Virology 2002, 293:234-242.
54. Sekellick MJ, Marcus PI: Persistent infection. II. Interferoninducing
temperature-sensitive mutants as mediators of cell
sparing: possible role in persistent infection by vesicular
stomatitis virus. Virology 1979, 95:36-47.
55. Bitnun A, Shannon P, Durward A, Rota PA, Bellini WJ, Graham C,
Wang E, Ford-Jones EL, Cox P, Becker L et al.: Measles
inclusion-body encephalitis caused by the vaccine strain of
measles virus. Clin Infect Dis 1999, 29:855-861.
56. Hambleton S, Goodbourn S, Young DF, Dickinson P,
Mohamad SM, Valappil M, McGovern N, Cant AJ, Hackett SJ,
Ghazal P et al.: STAT2 deficiency and susceptibility to viral
illness in humans. Proc Natl Acad Sci U S A 2013, 110:3053-3058.
57. Duncan CJA, Mohamad SMB, Young DA, Skelton AJ, Leahy TR,
Munday DC, Butler KM, Morfopoulou S, Brown JR, Hubank M,
Connell J, Gavin PJ, McMahon C, Dempsey E, Lynch NE,
Jacques TS, Valappil M, Cant AJ, Engelhardt K, Breuer J,
Randall RE, Hambleton S: Human IFNAR2 deficiency: lessons
for antiviral immunity. Sci Transl Med 2015, 7:307ra154.
58. Laidlaw SM, Dustin LB: Interferon lambda: opportunities, risks,
and uncertainties in the fight against HCV. Front Immunol 2014,
5:545.
59. Kainulainen L, Vuorinen T, Rantakokko-Jalava K, Osterback R,
Ruuskanen O: Recurrent and persistent respiratory tract viral
infections in patients with primary hypogammaglobulinemia.
J Allergy Clin Immunol 2010, 126:120-126.
60. Peltola V, Waris M, Kainulainen L, Kero J, Ruuskanen O: Virus
shedding after human rhinovirus infection in children, adults
and patients with hypogammaglobulinaemia. Clin Microbiol
Infect 2013, 19:E322-327.
61. Wilfert CM, Buckley RH, Mohanakumar T, Griffith JF, Katz SL,
Whisnant JK, Eggleston PA, Moore M, Treadwell E, Oxman MN
et al.: Persistent and fatal central-nervous-system ECHOvirus
infections in patients with agammaglobulinemia. N Engl J Med
1977, 296:1485-1489.
62. Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J: Twentyeight
years of poliovirus replication in an immunodeficient
individual: impact on the global polio eradication initiative.
PLoS Pathog 2015, 11:e1005114.
63. Roulston A, Marcellus RC, Branton PE: Viruses and apoptosis.
Annu Rev Microbiol 1999, 53:577-628.
64. Randall RE, Goodbourn S: Interferons and viruses: an interplay
between induction, signalling, antiviral responses and virus
countermeasures. J Gen Virol 2008, 89:1-47.
65. Griffin DE: Immune responses to RNA-virus infections of the
CNS. Nat Rev Immunol 2003, 3:493-502.
66. Dejuco N, Jegou B: Viruses in the mammalian male genital tract
and their effects on the reproductive system. Microbiol Mol Viol
Rev 2001, 65:208-231.
67. Petersen LR, Jamieson DJ, Powers AM, Honein MA: Zika virus. N
Engl J Med 2016, 374:1552-1563.
68. Crozier I: Ebola virus RNA in the semen of male survivors of
Ebola virus disease: the uncertain gravitas of a privileged
persistence. J Infect Dis 2016, 214:1467-1469.
69. Deen GF, Knust B, Broutet N, Sesay FR, Formenty P, Ross C,
Thorson AE, Massaquoi TA, Marrinan JE, Ervin E et al.: Ebola RNA
persistence in semen of ebola virus disease survivors—
preliminary report. N Engl J Med 2015:1-7.
70. Peterhans E, Schweizer M: Pestiviruses: how to outmaneuver
your hosts. Vet Microbiol 2010, 142:18-25.
71. Oldstone MB: Anatomy of viral persistence. PLoS Pathog 2009,
5:e1000523.
72. Fuccillo DA, Steele RW, Hensen SA, Vincent MM, Hardy JB,
Bellanti JA: Impaired cellular immunity to rubella virus in
congenital rubella. Infect Immun 1974, 9:81-84.
73. Oldstone MB: Viral persistence. Cell 1989, 56:517-520.
74. Borrow P: Mechanisms of viral clearance and persistence.
J Viral Hepat 1997, 4(Suppl. 2):16-24.
75. Melzi E, Caporale M, Rocchi M, Martin V, Gamino V, di Provvido A,
Marruchella G, Entrican G, Sevilla N, Palmarini M: Follicular
dendritic cell disruption as a novel mechanism of virusinduced
immunosuppression. Proc Natl Acad Sci U S A 2016,
113:E6238-E6247.
76. Rammohan KW, McFarland HF, McFarlin DE: Subacute
sclerosing panencephalitis after passive immunization and
natural measles infection: role of antibody in persistence of
measles virus. Neurology 1982, 32:390-394.
77. Maiztegui JI, Fernandez NJ, de Damilano AJ: Efficacy of immune
plasma in treatment of Argentine haemorrhagic fever and
association between treatment and a late neurological
syndrome. Lancet 1979, 2:1216-1217.
78. Oldstone MBA, Fujinami RS: Virus persistence and avoidance of
immune surveillance: how measles can be induced to persist
in cells, escape immune assault and injure tissues. In Virus
Persistence. Edited by Mahy BW, Minson AC, Darby GK.
Cambridge University Press; 1982:185-202.
79. Fujinami RS, Oldstone MB: Antigenic modulation: a mechanism
of viral persistence. Prog Brain Res 1983, 59:105-111.
80. Fujinami RS, Oldstone MB: Antiviral antibody reacting on the
plasma membrane alters measles virus expression inside the
cell. Nature 1979, 279:529-530.
81. Buchmeier MJ, de la Torre J, Peters CJ: Arenaviridae: the viruses
and their replication. In Fields Virology. Edited by Knipe DM,
Howley DM. Lippincott Williams & Wilkins; 2007:1791-1828.
82. Snijder EJ, Kikkert M, Fang Y: Arterivirus molecular biology and
pathogenesis. J Gen Virol 2013, 94:2141-2163.
83. de la Torre JC: Molecular biology of Borna disease virus and
persistence. Front Biosci 2002, 7:d569-d579.
84. Abbott KD, Ksiazek TG, Mills JN: Long-term hantavirus
persistence in rodent populations in central Arizona.
Emerg Infect Dis 1999, 5:102-112.
85. Sukhrie FH, Siebenga JJ, Beersma MF, Koopmans M: Chronic
shedders as reservoir for nosocomial transmission of
norovirus. J Clin Microbiol 2010, 48:4303-4305.
86. Bergmann CC, Lane TE, Stohlman SA: Coronavirus infection of
the central nervous system: host-virus stand-off. Nat Rev
Microbiol 2006, 4:121-132.
87. Roossinck MJ: Persistent plant viruses: molecular hitchhikers
or epigenetic elements? In Viruses: Essential Agents of Life.
Edited by Witzany G. Springer; 2012:177-186.
88. Gear JS, Cassel GA, Gear AJ, Trappler B, Clausen L, Meyers AM,
Kew MC, Bothwell TH, Sher R, Miller GB et al.: Outbreake of
Marburg virus disease in Johannesburg. Br Med J 1975,
4:489-493.
89. Memon MI, Memon MA: Hepatitis C: an epidemiological review.
J Viral Hepat 2002, 9:84-100.
90. Stapleton JT, Foung S, Muerhoff AS, Bukh J, Simmonds P: The GB
viruses: a review and proposed classification of GBV-A, GBVC
(HGV), and GBV-D in genus Pegivirus within the family
Flaviviridae. J Gen Virol 2011, 92:233-246.
91. Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D,
Davis B, Bowen R, Bunning M: Experimental infection of North
American birds with the New York 1999 strain of West Nile
virus. Emerg Infect Dis 2003, 9:311-322.
RNA virus persistence Randall and Griffin 41
www.sciencedirect.com Current Opinion in Virology 2017, 23:35–42
92. Ricklin ME, Garcia-Nicolas O, Brechbuhl D, Python S, Zumkehr B,
Nougairede A, Charrel RN, Posthaus H, Oevermann A,
Summerfield A: Vector-free transmission and persistence of
Japanese encephalitis virus in pigs. Nat Commun 2016,
7:10832.
93. Gritsun TS, Lashkevich VA, Gould EA: Tick-borne encephalitis.
Antiviral Res 2003, 57:129-146.
94. Peterhans E, Jungi TW, Schweizer M: BVDV and innate
immunity. Biologicals 2003, 31:107-112.
95. Nettleton PF, Entrican G: Ruminant pestiviruses. Br Vet J 1995,
151:615-642.
96. Dasgupta R, Free HM, Zietlow SL, Paskewitz SM, Aksoy S, Shi L,
Fuchs J, Hu C, Christensen BM: Replication of flock house virus
in three genera of medically important insects. J Med Entomol
2007, 44:102-110.
97. Pinsky BA, Mix S, Rowe J, Ikemoto S, Baron EJ: Long-term
shedding of influenza A virus in stool of immunocompromised
child. Emerg Infect Dis 2010, 16:1165-1167.
98. Olsen B, Munster VJ, Wallensten A, Waldenstrom J, Osterhaus AD,
Fouchier RA: Global patterns of influenza a virus in wild birds.
Science 2006, 312:384-388.
99. Rima BK, Duprex WP: Molecular mechanisms of measles virus
persistence. Virus Res 2005, 111:132-147.
100. Axthelm MK, Krakowka S: Experimental old dog encephalitis
(ODE) in a gnotobiotic dog. Vet Pathol 1998, 35:527-534.
101. Sharp CR, Nambulli S, Acciardo AS, Rennick LJ, Drexler JF,
Rima BK, Williams T, Duprex WP: Chronic infection of domestic
cats with feline morbillivirus, United States. Emerg Infect Dis
2016, 22:760-762.
102. Vandevelde M, Zurbriggen A: Demyelination in canine
distemper virus infection: a review. Acta Neuropathol 2005,
109:56-68.
103. Muchmore HG, Parkinson AJ, Humphries JE, Scott EN,
McIntosh DA, Scott LV, Cooney MK, Miles JA: Persistent
parainfluenza virus shedding during isolation at the South
Pole. Nature 1981, 289:187-189.
104. Atoynatan T, Hsiung GD: Epidemiologic studies of latent virus
infections in captive monkeys and baboons. II. Serologic
evidence of myxovirus infections with special reference to
SV5. Am J Epidemiol 1969, 89:472-479.
105. Cuevas-Romero S, Hernandez-Baumgarten E, Kennedy S,
Hernandez-Jauregui P, Berg M, Moreno-Lopez J: Long-term
RNA persistence of porcine rubulavirus (PorPV-LPMV) after an
outbreak of a natural infection: the detection of viral mRNA in
sentinel pigs suggests viral transmission. Virus Res 2014,
188:155-161.
106. Brahic M: Theiler’s virus infection of the mouse, or: of the
importance of studying animal models. Virology 2002, 301:1-5.
107. Schwarze J, O’Donnell DR, Rohwedder A, Openshaw PJ: Latency
and persistence of respiratory syncytial virus despite T cell
immunity. Am J Respir Crit Care Med 2004, 169:801-805.
108. Sikkel MB, Quint JK, Mallia P, Wedzicha JA, Johnston SL:
Respiratory syncytial virus persistence in chronic obstructive
pulmonary disease. Pediatr Infect Dis J 2008, 27:S63-S70.
109. Gomez B: Respiratory syncytial virus persistence. Virol Mycol
2012, 1:1-4.
110. Bingham J: Canine rabies ecology in southern Africa. Emerg
Infect Dis 2005, 11:1337-1342.
111. Banyard AC, Hayman D, Johnson N, McElhinney L, Fooks AR:
Bats and lyssaviruses. Adv Virus Res 2011, 79:239-289.
112. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B,
Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B et al.:
Chikungunya disease in nonhuman primates involves longterm
viral persistence in macrophages. J Clin Invest 2010,
120:894-906.
113. Weil ML, Itabashi H, Cremer NE, Oshiro L, Lennette EH, Carnay L:
Chronic progressive panencephalitis due to rubella virus
simulating subacute sclerosing panencephalitis. N Engl J Med
1975, 292:994-998.
114. Fujinami RS, von Herrath MG, Christen U, Whitton JL: Molecular
mimicry, bystander activation, or viral persistence: infections
and autoimmune disease. Clin Microbiol Rev 2006, 19:80-94.
115. Oldstone MB: Molecular mimicry and immune-mediated
diseases. FASEB J 1998, 12:1255-1265.
116. Chia JK: The role of enterovirus in chronic fatigue syndrome.
J Clin Pathol 2005, 58:1126-1132.
117. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH,
Melpolder JJ, Alter HJ: Long-term clinical and histopathological
follow-up of chronic posttransfusion hepatitis. Hepatology
1991, 14:969-974.
118. Lipton HL, Liang Z, Hertzler S, Son KN: A specific viral cause of
multiple sclerosis: one virus, one disease. Ann Neurol 2007,
61:514-523.
119. Virtanen JO, Jacobson S: Viruses and multiple sclerosis.
CNS Neurol Disord Drug Targets 2012, 11:528-544.
120. Roodman GD, Windle JJ: Paget disease of bone. J Clin Invest
2005, 115:200-208.
121. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT:
Chikungunya: a re-emerging virus. Lancet 2012, 379:662-671.
122. Julien J, Leparc-Goffart I, Lina B, Fuchs F, Foray S, Janatova I,
Aymard M, Kopecka H: Postpolio syndrome: poliovirus
persistence is involved in the pathogenesis. J Neurol 1999,
246:472-476.
123. Buchanan R, Bonthius DJ: Measles virus and associated central
nervous system sequelae. Semin Pediatr Neurol 2012,
19:107-114.
124. Wang JH, Kwon HJ, Jang YJ: Detection of parainfluenza virus
3 in turbinate epithelial cells of postviral olfactory dysfunction
patients. Laryngoscope 2007, 117:1445-1449.
125. Niedermeyer HP, Arnold W, Neubert WJ, Sedlmeier R: Persistent
measles virus infection as a possible cause of otosclerosis:
state of the art. Ear Nose Throat J 2000, 79:552-554 556,
558 passim.
126. Komune N, Ohashi M, Matsumoto N, Kimitsuki T, Komune S,
Yanagi Y: No evidence for an association between persistent
measles virus infection and otosclerosis among patients with
otosclerosis in Japan. J Clin Microbiol 2012, 50:626-632.